- 专利标题： DECIDUAL PLACENTAL MESENCHYMAL STEM CELL AND USE THEREOF IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR PROMOTING ANGIOGENESIS
-
申请号： EP21958020.6申请日： 2021-09-27
-
公开(公告)号： EP4410297A1公开(公告)日： 2024-08-07
- 发明人: CHU, Li-Li
- 申请人： Vitaspring Biomedical Co., Ltd.
- 申请人地址： TW New Taipei City, Taiwan 221416 10F.-11, No. 93, Sec. 1 Xintai 5th Rd. Xizhi Dist.
- 专利权人： Vitaspring Biomedical Co., Ltd.
- 当前专利权人： Vitaspring Biomedical Co., Ltd.
- 当前专利权人地址： TW New Taipei City, Taiwan 221416 10F.-11, No. 93, Sec. 1 Xintai 5th Rd. Xizhi Dist.
- 代理机构： Lang, Christian
- 国际申请： CN2021120946 2021.09.27
- 国际公布： WO2023044902 2023.03.30
- 主分类号： A61K35/50
- IPC分类号： A61K35/50 ; C12N5/0775
摘要：
Provided in the present invention are a decidual placental mesenchymal stem cell and a culture method therefor. The method comprises: in an existing culture method for a mesenchymal stem cell, an induction step is added, so that the decidual placental mesenchymal stem cell highly expresses Decoy receptor 3 (DcR3). Further provided in the present invention is the use of the decidual placental mesenchymal stem cell in the preparation of a drug for promoting angiogenesis.
信息查询
IPC分类:
